The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis
Abstract
CONTEXT: The long-term cardiovascular safety of widely used oral contraceptives (OCs) is still debated, and no meta-analysis assesses the modern use of OCs and the associated cardiovascular risks. OBJECTIVE: We aimed to assess the risk of cardiovascular diseases associated with current use of low-dose combined OCs. DATA SOURCES: All studies published between January 1980 and October 2002 were searched using MEDLINE, BIOSIS, and Scientific Citations. STUDY SELECTION: Original studies were selected independently by two investigators (J.P.B., P.A.E.) based on inclusion criteria: low-dose combined OC (<50 mug of ethinyl-estradiol); more than 10 cases in low-dose users; clear definition of cases; concurrent controls; and control for age. A third investigator (J.E.N.) adjudicated disagreements. From 2715 identified articles, 14 independent studies were included. DATA EXTRACTION: All data were abstracted by one investigator (J.P.B.) in a systematic manner. Classification of OCs and types of exposure were directly abstracted from studies. Current use was defined as use at the time of the event or within 3 months. Only peer-reviewed studies with definition of events as definite or possible, based on prespecified criteria, were included. DATA SYNTHESIS: The summary risk estimates associated with current use of low-dose OCs were 1.84 [95% confidence interval (CI) = 1.38, 2.44] for myocardial infarctions and 2.12 (95% CI = 1.56, 2.86) for ischemic strokes. The overall summary odds ratio for both outcomes was 2.01 (95% CI = 1.63, 2.48). Second generation OCs were associated with a significant increased risk of both myocardial infarction and ischemic stroke events [1.85 (95% CI = 1.03,3.32) and 2.54 (95% CI = 1.96,3.28), respectively]; and third-generation OCs, for ischemic stroke outcome only [2.03 (95% CI = 1.15,3.57)]. CONCLUSIONS: In conclusion, a rigorous meta-analysis of the literature suggests that current use of low-dose OCs significantly increases the risk of both cardiac and vascular arterial events, including a significant risk of vascular arterial complications with third generation OCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International diagnostic criteria for acute myocardial infarction and acute stroke
Gillum, R. F., Fortmann, S. P., Prineas, R. J., & Kottke, T. E. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90558-1 · Cited by 484
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 455
Ischemic Stroke Risk With Oral Contraceptives: A Meta-analysis
Gillum, L. A., Mamidipudi, S. K., & Johnston, S. C. (2000) · JAMA · doi:10.1001/jama.284.1.72 · Cited by 402
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
Krattenmacher, R. (2000) · Contraception · doi:10.1016/s0010-7824(00)00133-5 · Cited by 376
(1996) · The Lancet · doi:10.1016/s0140-6736(95)12393-8 · Cited by 334
Stroke in Users of Low-Dose Oral Contraceptives
Petitti, D. B., Sidney, S., Bernstein, A., Wolf, S., Quesenberry, C., & Ziel, H. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350102 · Cited by 329
Combination Estrogen–Progestin Oral Contraceptives
Petitti, D. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030751 · Cited by 242
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2002) · Obstetrical and Gynecological Survey · doi:10.1097/00006254-200205000-00021 · Cited by 225
Kemmeren, J. M., Tanis, B. C., van den Bosch, M. A. A. J., Bollen, E. L. E. M., Helmerhorst, F. M., van der Graaf, Y., Rosendaal, F. R., & Algra, A. (2002) · Stroke · doi:10.1161/01.str.0000015345.61324.3f · Cited by 222
Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard, O. (1993) · BMJ · doi:10.1136/bmj.306.6883.956 · Cited by 216
Contraceptivos orales y riesgo de infarto de miocardio
Tanis, B. C. (2001) · New England Journal of Medicine · Cited by 193
Incidence of Stroke and Myocardial Infarction in Women of Reproductive Age
Petitti, D. B., Sidney, S., Quesenberry, C. P., & Bernstein, A. (1997) · Stroke · doi:10.1161/01.str.28.2.280 · Cited by 181
Chan, W.-S., Ray, J., Wai, E. K., Ginsburg, S., Hannah, M. E., Corey, P. N., & Ginsberg, J. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.741 · Cited by 171
Dunn, N., Thorogood, M., Faragher, B., de Caestecker, L., MacDonald, T. M., McCollum, C., Thomas, S., Mann, R., & Lidegaard, O. (1999) · BMJ · doi:10.1136/bmj.318.7198.1579 · Cited by 169
The use of oral contraceptives and the occurrence of acute myocardial infarction in young women
Lewis, M. A., Heinemann, L. A. J., Spitzer, W. O., MacRae, K. D., & Bruppacher, R. (1997) · Contraception · doi:10.1016/s0010-7824(97)00118-2 · Cited by 163
Oral contraceptives use and the risk of myocardial infarction: a meta-analysis
Khader, Y. S., Rice, J. C., Lefante, J., & Abueita, O. (2003) · Contraception · doi:10.1016/s0010-7824(03)00073-8 · Cited by 153
Insulin Sensitizers for Polycystic Ovary Syndrome
Baillargeon, J., Iuorno, M. J., & Nestler, J. E. (2003) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200306000-00011 · Cited by 148
Self-citationContraceptives and cerebral thrombosis: a five-year national case-control study☆
Lidegaard, Ø., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00306-7 · Cited by 134
Myocardial Infarction and Use of Low-Dose Oral Contraceptives
Sidney, S., Siscovick, D. S., Petitti, D. B., Schwartz, S. M., Quesenberry, C. P., Psaty, B. M., Raghunathan, T. E., Kelaghan, J. W., & Koepsell, T. D. (1998) · Circulation · doi:10.1161/01.cir.98.11.1058 · Cited by 112
Use of Low-Dose Oral Contraceptives and Stroke in Young Women
Schwartz, S. M., Siscovick, D. S., Longstreth, W. T., Jr., Psaty, B. M., Beverly, R. K., Raghunathan, T. E., Lin, D., & Koepsell, T. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_1-199710150-00003 · Cited by 111
Low-Dose Oral Contraceptive Use and the Risk of Myocardial Infarction
Rosenberg, L. A., Palmer, J. R., Rao, S. R., & Shapiro, S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.8.1065 · Cited by 103
Thromboembolic Stroke in Young Women
Heinemann, L. A. J., Lewis, M. A., Spitzer, W. O., Thorogood, M., Guggenmoos-Holzmann, I., & Bruppacher, R. (1998) · Contraception · doi:10.1016/s0010-7824(97)00204-7 · Cited by 85
Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill
Siritho, S., Thrift, A. G., McNeil, J. J., You, R. X., Davis, S. M., & Donnan, G. A. (2003) · Stroke · doi:10.1161/01.str.0000077925.16041.6b · Cited by 84
Current perspectives on oral contraceptive use
Burkman, R. T., Collins, J. A., SHULMAN, L. P., & Williams, J. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117416 · Cited by 80
Thrombotic diseases in young women and the influence of oral contraceptives
Lidegaard, Ø. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1053/ob.1998.v179.a91674 · Cited by 77
Thorogood, M., Mann, J. I., Murphy, M. F. G., & Vessey, M. P. (1991) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb15397.x · Cited by 75
Contraception for Women in Selected Circumstances
Curtis, K. M., Chrisman, C. E., & Peterson, H. B. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)01984-1 · Cited by 58
Myocardial infarction and third generation oral contraceptives: aggregation of recent studies
Spitzer, W. O. (2002) · Human Reproduction · doi:10.1093/humrep/17.9.2307 · Cited by 49
Dunn, N. R., Arscott, A., & Thorogood, M. (2001) · Contraception · doi:10.1016/s0010-7824(01)00172-x · Cited by 32
Nestler, J. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00318-5 · Cited by 28
Self-citationEmerging evidence on oral contraceptives and arterial disease
Heinemann, L. A. J. (2000) · Contraception · doi:10.1016/s0010-7824(00)00146-3 · Cited by 14
Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
Baillargeon, J., Iuorno, M. J., & Nestler, J. E. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00003 · Cited by 14
Self-citation
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941
Metadata
- Authors
- Baillargeon, J.-P., McClish, D. K., Essah, P. A., & Nestler, J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07
- Volume
- 90
- Issue
- 7
- Pages
- 3863-3870
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1998181443
- Cited by
- 297
- References
- 33
- FWCI
- 16.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.